MB-1 Impact on Metabolic Health in Overweight and Obese Adults

This clinical trial focuses on exploring the safety and efficacy of a treatment called MB-1 in improving metabolic health among adults who are overweight or obese. The primary aim is to understand if MB-1 can lead to significant changes in body weight and Body Mass Index (BMI) when compared to a placebo. This study is important as it could potentially offer a new approach to manage weight and related health issues in overweight and obese individuals, thereby addressing a common health challenge. In this trial, participants are given either MB-1 or a placebo. Throughout the study, various measurements are taken such as body weight, BMI, blood pressure, and heart rate. Participants are also asked to complete questionnaires about their appetite and feelings of fullness, and undergo a DEXA scan, which is a type of X-ray that measures body composition. The study's main outcome measure is the difference in body weight and BMI changes from the start of the trial to Day 84 between the MB-1 and placebo groups.